The forkhead transcription factor Foxl2 is sumoylated in both human and mouse: Sumoylation affects its stability, localization, and activity

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Marongiu, Mara ^a   Deiana, Manila ^a   Meloni, Alessandra ^a   Marcia, Loredana ^a   Puddu, Alessandro ^a,b   Cao, Antonio ^a   Schlessinger, David ^c   Crisponi, Laura ^a  

^a CNR   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; FORKHEAD TRANSCRIPTION FACTOR FOXL2; PROTEIN INHIBITOR OF ACTIVATED STAT; PROTEIN UBC9; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; FOXL2 PROTEIN, HUMAN; FOXL2 PROTEIN, MOUSE; SUMO 1 PROTEIN; UBIQUITIN CONJUGATING ENZYME; UBIQUITIN CONJUGATING ENZYME UBC9; UBIQUITIN-CONJUGATING ENZYME UBC9;

ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVITY; CELL LINE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEMALE; GENETIC TRANSFECTION; GONAD; HUMAN; HYBRIDIZATION; MOUSE; NONHUMAN; PROTEIN PROTEIN INTERACTION; SCREENING; SUMOYLATION; TRANSCRIPTION REGULATION; YEAST CELL; ANIMAL; C57BL MOUSE; CELL STRAIN COS1; CERCOPITHECUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; MALE; METABOLISM; MUTATION;

MUS;

ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; MALE; MICE; MICE, INBRED C57BL; MUTATION; PROTEIN INHIBITORS OF ACTIVATED STAT; SUMO-1 PROTEIN; UBIQUITIN-CONJUGATING ENZYMES;

EID: 77949720991     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009477     Document Type: Article

References (23)

1. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, et al. (2001) The putative forkhead transcription factor FOXL2 is mutated in blepharophimosis/ptosis/ epicanthus inversus syndrome. Nat. Genet 27: 159-66.
2. Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, et al. (2004) Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13: 1171-81.
3. Ottolenghi C, Omari S, Garcia-Ortiz JE, Uda M, Crisponi L, et al. (2005) Foxl2 is required for commitment to ovary differentiation. Hum Mol Genet 14: 2053-62.
4. Ottolenghi C, Pelosi E, Tran J, Colombino M, Douglass E, et al. (2007) Loss of Wnt4 and Foxl2 leads to female-to-male sex reversal extending to germ cells. Hum Mol Genet 16: 2795-804.
5. Wagner T, Wirth J, Meyer J, Zabel B, Held M, et al. (1994) Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79: 1111-20.
6. Hattori T, Eberspaecher H, Lu J, Zhang R, Nishida T, et al. (2006) Interactions between PIAS proteins and SOX9 result in an increase in the cellular concentrations of SOX9. J Biol Chem 281: 14417-28.
7. Oh HJ, Kido T, Lau YF (2007) PIAS1 interacts with and represses SOX9 transactivation activity. Mol Reprod Dev 74: 1446-55.
8. Hay RT (2005) SUMO: a history of modification. Mol Cell 18: 1-12.
9. Geiss-Friedlander R, Melchior F (2007) Concepts in sumoylation: a decade on. Nat Rev Mol Cell Biol 8: 947-56.
10. Seeler JS, Marchio A, Losson R, Desterro JM, Hay RT, et al. (2001) Common properties of nuclear body protein SP100 and TIF1alpha chromatin factor: role of SUMO modification. Mol Cell Biol 21: 3314-3324.
11. Zhong S, Muller S, Ronchetti S, Freemont PS, Dejean A, et al. (2000) Role of SUMO-1-modified PML in nuclear body formation. Blood 95: 2748-2752.
12. Voet D, Voet JG (2004) Biochemistry, 3rd Ed., Wiley, 515p-528p, 1352p-1365p.
13. Shao R, Zhang FP, Rung E, Palvimo JJ, Huhtaniemi I, et al. (2004) Inhibition of small ubiquitin-related modifier-1 expression by luteinizing hormone receptor stimulation is linked to induction of progesterone receptor during ovulation in mouse granulosa cells. Endocrinology 145: 384-92.
14. Shao R, Rung E, Weijdega° rd B, Billig H (2006) Induction of apoptosis increases SUMO-1 protein expression and conjugation in mouse periovulatory granulosa cells in vitro. Mol Reprod Dev 73: 50-60.
15. Ellsworth BS, Burns AT, Escudero KW, Duval DL, Nelson SE, et al. (2003) The gonadotropin releasing hormone (GnRH) receptor activating sequence (GRAS) is a composite regulatory element that interacts with multiple classes of transcription factors including Smads, AP-1 and a forkhead DNA binding protein. Mol Cell Endocrinol 206: 93-111.
16. Ellsworth BS, Egashira N, Haller JL, Butts DL, Cocquet J, et al. (2006) FOXL2 in the pituitary: molecular, genetic, and developmental analysis. Mol Endocrinol 20: 2796-805.
17. Pisarska MD, Bae J, Klein C, Hsueh AJ (2004) Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 145: 3424-33.
18. Crisponi L, Uda M, Deiana M, Loi A, Nagaraja R, et al. (2004) FOXL2 inactivation by a translocation 171 kb away: analysis of 500 kb of chromosome 3 for candidate long-range regulatory sequences. Genomics 83: 757-64.
19. Vigodner M, Morris PL (2005) Testicular expression of small ubiquitin-related modifier-1 (SUMO-1) supports multiple roles in spermatogenesis: silencing of sex chromosomes in spermatocytes, spermatid microtubule nucleation, and nuclear reshaping. Dev Biol 282: 480-92.
20. Vigodner M, Ishikawa T, Schlegel PN, Morris PL (2006) SUMO-1, human male germ cell development, and the androgen receptor in the testis of men with normal and abnormal spermatogenesis. Am J Physiol Endocrinol Metab 290: E1022-33.
21. Benayoun BA, Auer J, Caburet S, Veitia RA (2008) The post-translational modification profile of the forkhead transcription factor FOXL2 suggests the existence of parallel processive/concerted modification pathways. Proteomics 8: 3118-23.
22. Kuo FT, Bentsi-Barnes IK, Barlow GM, Bae J, Pisarska MD (2009) Sumoylation of forkhead L2 by Ubc9 is required for its activity as a transcriptional repressor of the Steroidogenic Acute Regulatory gene. Cell Signal 21(12): 1935-44.
23. Ottolenghi C, Uda M, Crisponi L, Omari S, Cao A, et al. (2007) Determination and stability of sex. Bioessays 29: 15-25.